β-胡萝卜素对骨质疏松症的影响:观察性研究的系统评价与荟萃分析
该系统评价与荟萃分析纳入15项观察性研究,比较低β-胡萝卜素摄入组与高摄入组,发现β-胡萝卜素摄入与总体骨质疏松风险无关(OR=0.733,95%CI 0.528-1.018,p=0.064),但在男性和女性亚组及亚洲亚组中呈负相关,且与总体骨密度呈正相关。
要点
- β-胡萝卜素摄入与总体骨质疏松风险无关(OR=0.733,95%CI 0.528-1.018,p=0.064)。
- 男性亚组OR=0.7(95%CI 0.549-0.893,I²=40.40%,p=0.004),女性亚组OR=0.684(95%CI 0.487-0.960,I²=86.40%,p=0.028)。
- 亚洲亚组OR=0.512(95%CI 0.403-0.650,I²=0.00%,p=0),西方亚组无关联(OR=1.107,95%CI 0.908-1.350,I²=2.30%,p=0.314)。
核心结论
- β-胡萝卜素可能改善骨密度并降低骨质疏松和骨折风险,但效果可能因性别和种族而异,需进一步纵向研究验证。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase、Web of Science和Cochrane Library,纳入15项观察性研究,采用随机效应模型合并OR和SMD。
主要发现
- β-胡萝卜素摄入与总体骨质疏松风险无关(OR=0.733,95%CI 0.528-1.018,p=0.064)。
- 男性亚组骨质疏松风险降低(OR=0.7,95%CI 0.549-0.893,I²=40.40%,p=0.004),女性亚组亦降低(OR=0.684,95%CI 0.487-0.960,I²=86.40%,p=0.028)。
- 亚洲亚组骨质疏松风险降低(OR=0.512,95%CI 0.403-0.650,I²=0.00%,p=0),西方亚组无关联(OR=1.107,95%CI 0.908-1.350,I²=2.30%,p=0.314)。
- β-胡萝卜素摄入与总体骨密度呈正相关(SMD=-0.213,95%CI -0.391至-0.034,I²=87.30%,p=0.019)。
- 亚洲参与者骨密度正相关(SMD=-0.394,95%CI -0.461至-0.328,I²=0,p=0),西方参与者无关联(SMD=-0.047,95%CI -0.314至0.219,I²=78.9%,p=0.727)。
局限性
- β-胡萝卜素对骨质疏松和骨折的效果可能因性别和种族而异,需进一步纵向研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim is to evaluate the effect of β-carotene for osteoporosis and provide quantitative evidence. METHOD: PubMed, Embase, Web of Science, and Cochrane Library were searched for eligible studies. Fifteen studies were included. Random-effect model was applied to pool the odds ratio (OR). The risk of osteoporosis and fracture were compared between low β-carotene intake group and high β-carotene intake group. RESULT: The intake of β-carotene was unassociated with the overall risk of osteoporosis [OR = 0.733, 95% Cl (0.528, 1.018), p = 0.064]. Subgroup analysis showed that the intake of β-carotene was negatively associated with the risk of osteoporosis in both male subgroup [OR = 0.7, 95% Cl (0.549, 0.893), I2 = 40.40%, p = 0.004] and female subgroup [OR = 0.684, 95% Cl (0.487, 0.960), I2 = 86.40%, p = 0.028]. There was also a negative association between β-carotene intake and osteoporosis in Asia subgroup [OR = 0.512, 95% Cl (0.403, 0.650), I2 = 0.00%, p = 0], whereas no association was observed in Western subgroup [OR = 1.107, 95% Cl (0.908, 1.350), I2 = 2.30%, p = 0.314]. In addition, random-effect model was adopted to pool the standard mean difference (SMD), and the results showed that β-carotene intake was positively associated with overall bone mineral density (BMD) [SMD = - 0.213, 95% Cl (- 0.391, - 0.034), I2 = 87.30%, p = 0.019]. Subgroup analysis showed that β-carotene intake was positively associated with BMD in Asian participants [SMD = - 0.394, 95% Cl (- 0.461, - 0.328), I2 = 0, p = 0], while unassociated in Western participants [SMD = - 0.047, 95% Cl (- 0.314, 0.219), I2 = 78.9%, p = 0.727]. CONCLUSION: β-carotene may improve BMD and reduce the risk of osteoporosis and fracture. However, these effects could vary by gender and race and need to be further validated by longitudinal studies.
引用
- Gao SS, Zhao Y. The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies. Osteoporos Int. 2022. PMID: 36380163. doi:10.1007/s00198-022-06593-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。